# Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCC

> **NCT04212273** · NA · UNKNOWN · sponsor: **Tianjin Third Central Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Hepatocellular Cancer
- Liver Cirrhoses
- Diagnoses Disease

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic Sonazoid-CEUS and EOB-MRI

## Key facts

- **NCT ID:** NCT04212273
- **Lead sponsor:** Tianjin Third Central Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-21
- **Primary completion:** 2022-12-24
- **Final completion:** 2022-12-24
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04212273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04212273, "Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04212273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*